Can Mitochondrial Ribosomal Proteins Serve as Biomarkers for Cancer?
Yes, mitochondrial ribosomal proteins (MRPs) have the potential to serve as biomarkers for cancer. Several studies have identified specific MRPs that are upregulated or downregulated in various types of cancer. For instance, MRPL41 has been found to be downregulated in breast cancer, while MRPS23 is upregulated in colorectal cancer. These alterations can be utilized to develop diagnostic tools or to monitor treatment responses.
